EBITDA: Income before interest, taxes, depreciation and amortization.
Guardant Health, Inc. (GH) had EBITDA of $-116.63M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$281.27M |
|
$-128.49M |
|
$99.49M |
|
$181.77M |
|
$402.07M |
|
$-120.81M |
|
$-9.42M |
|
$-130.22M |
|
$-130.22M |
|
$-128.49M |
|
$-128.49M |
|
$-128.49M |
|
$-128.49M |
|
$-120.81M |
|
|
EBITDA |
$-116.63M |
125.37M |
|
125.37M |
|
$-1.01 |
|
$-1.01 |
|
| Balance Sheet Financials | |
$1.47B |
|
$145.91M |
|
$547.61M |
|
$2.01B |
|
$302.73M |
|
$1.50B |
|
$1.81B |
|
$2.11B |
|
$-99.31M |
|
$-202.49M |
|
$-99.31M |
|
130.63M |
|
| Cash Flow Statement Financials | |
$-184.76M |
|
$-627.20M |
|
$671.13M |
|
$629.75M |
|
$489.42M |
|
$-140.34M |
|
$166.22M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.84 |
|
-- |
|
-- |
|
1.07 |
|
-15.14 |
|
64.63% |
|
-42.95% |
|
-42.95% |
|
-- |
|
-46.30% |
|
-45.68% |
|
$-233.07M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
1.16 |
|
2.04 |
|
44.11 |
|
129.39% |
|
63.46% |
|
-6.38% |
|
-9.15% |
|
$-0.76 |
|
$-1.86 |
|
$-1.47 |
|